Results Of Phase I Study Of Pembrolizumab In Combination With Binimetinib In Patients With Unresectable Locally Advanced Or Metastatic Triple Negative Breast Cancer.
CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2021)